Table 6.
Characteristics of the studies evaluating fish intake, n-3 LC-PUFA intake and fish oil supplements and cancers
| Author | Outcomes | Type of study | Exposure | Results | Conclusion |
|---|---|---|---|---|---|
| Wu et al., 2012 Am J Med. | Colorectal cancer | MA 22 prospective cohort studies (N = 1,209,489 participants in total with 7,483 cases) and 19 case-control studies |
Fish consumption, highest versus lowest | Fish consumption decreased the risk of colorectal cancer by 12% (summary OR, 0.88; 95% CI, 0.80–0.95). The pooled ORs of colorectal cancer for the highest versus lowest fish consumption in case-control studies and cohort studies were 0.83 (95% CI, 0.72–0.95) and 0.93 (95% CI, 0.86–1.01), respectively. |
Findings suggest that fish consumption is inversely associated with colorectal cancer. |
|
Vieira et al., 2017
Ann Oncol |
Colorectal cancer | MA & SR 11 studies included in the dose-response meta-analysis 10,356 cases |
Fish consumption, highest versus lowest | An increase of 100 g/day of fish was associated with lower risk of colorectal cancer, RR 0.89(95% CI 0.80–0.99) | The inverse association for fish intake showed low credibility because the results were mainly driven by one study in the analysis (40% weight). |
|
Schwingshackl et al., 2018 Int. J. Cancer |
Colorectal cancer | MA & SR 21 studies examined (cohort studies, case–cohort studies, follow-up of RCTs and nested case–control studies) 19,996 cases |
Fish consumption, highest versus lowest | Overall risk estimates of 0.95 (0.87 to 1.03) per 100 grams fish per day There was no evidence of a nonlinear dose-response (15 studies included) |
No statistically significant association was observed between fish intake and risk of colorectal cancer. However, an inverse association was observed for studies conducted in Europe, for long-term studies, and studies with 1,000 cases or more. |
|
Lovegrove et al., 2015 Int J Clin Pract |
Prostate cancer | SR 37 studies in total (case-control and cohort) 31 on PCa risk 8 on aggressiveness 3 on mortality 495,321 participants in total |
Fish intake Fish oil intake |
Overall, 10 studies considering PC-risk found significant inverse trends with fish and fish-oil intake. Three studies investigating fish consumption and PC-mortality identified a significantly reduced risk. Multivariate-OR (95% CI) were 0.9 (0.6–1.7), 0.12 (0.05–0.32) and 0.52 (0.30–0.91) at highest fish intakes. |
Total fish and fish oil intake was not associated with prostate cancer risk but may be implicated in lower mortality risk. |
|
Aucoin et al., 2017 Integrative Cancer Therapies |
Prostate cancer | SR 11 cohort studies on primary prevention (17 publications) 13 publications on diet, one on supplement and 3 on both |
Fish intake Fish oil |
Of the analyses assessing prostate cancer incidence prospective, 12 did not show a statistically significant association. Five analyses showed a significant association between increased intake of fish-derived omega-3 fatty acids and decreased prostate cancer incidence. | Insufficient evidence to suggest a relationship between fish-derived omega-3 fatty acid and risk of prostate cancer. An association between higher omega-3 intake and decreased prostate cancer mortality may be present, but more research is needed |
|
Zheng et al., 2013 BMJ |
Breast cancer | MA & SR 21 cohort studies 11 studies on fish intake 687,770 participants 13,323 cases 17 studies on marine n-3 PUFA 527,392 participants 16,178 |
Fish intake n-3 LC-PUFA from diet or as tissue biomarker |
High fish intake yielded overall risk estimate of 1.03 (0.93–1.14) High intake of n-3 LC-PUFA from diet yielded overall risk estimate of 0.86 (0.78–0.94) |
High intake of n-3 LC-PUFA is associated with 14% reduction in risk of breast cancer |
|
Wu et al., 2016 Nutrients |
Breast cancer | MA 18 cohort studies 914,451 participants 19,400 cases |
Fish intake (highest vs. Lowest and dose-response) | The summary RR for highest versus lowest was 1.04 (95% CI 0.97 to 1.12) Dose-response analysis showed that the summary RR per 120 g/day was 1.07 (95% CI 0.94 to 1.21) |
A null association was observed for fish intake and risk of breast cancer. |
|
Kazemi et al., 2021 Adv Nutr |
Breast cancer | SR and MA Included were cohort, case-cohort, nested casecontrol studies, and follow-up studies of randomized controlled trials 17 studies 28,818 cases |
Fish intake (dose-response) | Dose-response analysis showed that the summary RR per 100 g/day increase was 1.0 (95% CI 0.93 to 1.08) | A null association was observed for fish intake and risk of breast cancer. |
Selection of topics for systematic reviews for the NNR2022 project
RR, Relative risk/Risk ratio; PUFA, polyunsaturated fatty acids; PCa, prostate cancer; SR, systematic review; MA, meta-analysis; RCT, randomized controlled trial; OR, Odds ratio; RR, Relative risk/Risk ratio.